Am J Respir Crit Care Med

1. MENDEZ R, Gonzalez-Jimenez P, Latorre A, Piqueras M, et al
   The Long-term Pneumonia Mortality Index. An International Multicenter Derivation and Validation Study for Patients with Community-Acquired Pneumonia.
   Am J Respir Crit Care Med. 2026 Feb 21:aamag060. doi: 10.1093.
   

   >> Share

   
   
2. GAERTNER VD, Ramin-Wright L, Waldmann AD, Belting C, et al
   The first breaths after birth-early lung function in healthy term infants.
   Am J Respir Crit Care Med. 2026 Jan 30:aamag008. doi: 10.1093.
   

   >> Share

   
   

   
   Ann Intern Med

3. QASEEM A, Obley AJ, Harrod CS, Wilt TJ, et al
   COVID-19 Vaccines for 2025-2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
   Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05026.
   

   >> Share

   
   
4. 
   Annals Video Summary - COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised.
   Ann Intern Med. 2026 Feb 24:e2600306VS. doi: 10.7326/ANNALS-26-00306.
   

   >> Share

   
   
5. 
   Summary for Patients: COVID-19 Vaccines for 2025-2026.
   Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05026.
   

   >> Share

   
   
6. DOBRESCU A, Pinte L, Sharifan A, Gadinger A, et al
   Effectiveness, Comparative Effectiveness, and Harms of COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
   Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05044.
   

   >> Share

   
   

   
   Antiviral Res

7. ZHANG T, Wang ZL, Li XY, Luo RH, et al
   Onvansertib and vilazodone inhibit SARS-CoV-2 replication via suppression of METTL3 RNA-m(6)A enzymatic activity.
   Antiviral Res. 2026 Feb 19:106376. doi: 10.1016/j.antiviral.2026.106376.
   

   >> Share

   
   

   
   Clin Infect Dis

8. NELLORE A, Bajema K, Belden K, Blumberg D, et al
   IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19 infections in immunocompromised patients.
   Clin Infect Dis. 2026 Feb 25:ciag115. doi: 10.1093.
   

   >> Share

   
   

   
   Int J Infect Dis

9. ALVES COSTA SILVA C, Pinheiro Bomfim A, Dutra Medeiros J, de Jesus Silva J, et al
   Corrigendum to "Nasal microbiota and clinical features in acute flu-like illness: COVID-19 status and long COVID follow-up" [International Journal of Infectious Diseases 162 (2026) 108196 https://doi.org/10.1016/j.ijid.2025.108196].
   Int J Infect Dis. 2026;165:108441.
   

   >> Share

   
   

   
   J Infect

10. ORDONEZ-MENA JM, Radin JM, Hoang U, Araujo AB, et al
    Epidemiology of virologically confirmed RSV, influenza and COVID-19 in adults in England, 2023-2024: Primary Care Observational Study of Acute Respiratory Infection (ObservatARI).
    J Infect. 2026 Feb 21:106714. doi: 10.1016/j.jinf.2026.106714.
    

    >> Share

    
    

    
    J Med Virol

11. PHUONG LE UN, Chou RH, Lin CS, Lai HC, et al
    SARS-CoV-2 Main Protease Activates ERK1/2 Signaling to Facilitate MEG2-STAT3-Mediated Suppression of ACE2.
    J Med Virol. 2026;98:e70855.
    

    >> Share

    
    
12. 
    EXPRESSION OF CONCERN: The Emergence, Spread and Vanishing of a French SARS-CoV-2 Variant Exemplifies the Fate of RNA Virus Epidemics and Obeys the Mistigri Rule.
    J Med Virol. 2026;98:e70842.
    

    >> Share

    
    

    
    J Virol

13. NOORUZZAMAN M, Butt SL, Rani R, Ye C, et al
    The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infection.
    J Virol. 2026 Feb 27:e0064425. doi: 10.1128/jvi.00644.
    

    >> Share

    
    

    
    Nature

14. VENTER M, Manuguerra JC, Watson JM, Fischer TK, et al
    COVID's origins: what we do and don't know.
    Nature. 2026;650:829-833.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share